India leads meningitis A vaccine development.
Das
Manjulika
M
D006801:Humans; D007194:India; D016920:Meningitis, Bacterial / Q000276:immunology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000737:chemistry* / Q000276:immunology; D011135:Polysaccharides, Bacterial / Q000276:immunology; D013745:Tetanus Toxoid / Q000276:immunology; D018074:Vaccines, Conjugate / Q000737:chemistry / Q000276:immunology
D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; D013745:Tetanus Toxoid; D018074:Vaccines, Conjugate; C036112:streptococcal polysaccharide group A